Physician profile
Munir E Hazbun
NPI 1467492868
$8,054.72
in general payments reported to CMS, 2019-2025
39 companies · $2,676 in 2025
The $2,676 reported for 2025 was more than what 89% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2021: $173 · 2022: $591 · 2023: $1,357 · 2024: $3,116 · 2025: $2,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,275 · Travel and Lodging: $821 · Education: $53.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,275.21 |
| Travel and Lodging | $820.52 |
| Education | $53.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,970.81 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $1,112.98 | 2021-2025 | Nucala, Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $466.51 | 2022-2025 | Ofev, Jascayd |
| Astrazeneca Pharmaceuticals LP | $443.75 | 2021-2025 | Fasenra, Tezspire, Airsupra |
| Insmed, INC. | $319.62 | 2024-2025 | Arikayce, Brinsupri |
| Baxter Healthcare | $304.24 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Genzyme Corporation | $302.32 | 2021-2025 | |
| Novo Nordisk INC | $228.24 | 2023-2025 | Ozempic |
| Lilly USA, LLC | $221.72 | 2025 | Zepbound |
| Aop Health US, LLC | $214.69 | 2025 | Rapiblyk |
| Harmony Biosciences LLC | $179.21 | 2024 | |
| Inari Medical, INC. | $154.02 | 2022 | |
| Paratek Pharmaceuticals, INC. | $141.80 | 2021-2024 | Nuzyra |
| Zoll Respicardia, INC. | $140.67 | 2019 | |
| Itamar Medical INC | $139.06 | 2022-2024 | Watchpatone |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $137.12 | 2024 | Zephyr Delivery Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Grifols USA, LLC | $136.84 | 2024-2025 | Prolastin-C Liquid |
| Philips North America LLC | $132.47 | 2023-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Takeda Pharmaceuticals U.S.A., INC. | $125.94 | 2023-2025 | Glassia |
| Abbvie INC. | $121.03 | 2024-2025 | |
| Electromed, INC. | $115.67 | 2021-2025 | Smartvest |
| Jazz Pharmaceuticals INC. | $110.22 | 2024-2025 | |
| Amgen INC. | $108.20 | 2023-2025 | Tezspire |
| Actelion Pharmaceuticals US, INC. | $92.23 | 2024-2025 | Opsumit, Uptravi |
| Pfizer INC. | $87.33 | 2025 | |
| Merck Sharp & Dohme LLC | $76.30 | 2022-2024 | Zerbaxa, Recarbrio |
| Regeneron Healthcare Solutions, INC. | $73.96 | 2024-2025 | Dupixent |
| Resmed Corp | $53.96 | 2024 | |
| 3b Medical, INC. | $51.16 | 2025 | Luna |
| United Therapeutics Corporation | $48.99 | 2025 | Tyvaso |
| Mallinckrodt Hospital Products INC. | $48.45 | 2023-2024 | Acthar |
| Caris Mpi, INC. | $33.24 | 2025 | Mi Cancer Seek |
| Teva Pharmaceuticals USA, INC. | $31.02 | 2021-2023 | |
| Vifor Pharma, INC. | $29.17 | 2024 | Zemaira |
| Ani Pharmaceuticals, INC. | $27.16 | 2024 | Purified Cortrophin Gel |
| Stryker Corporation | $25.18 | 2025 | Clottriever Bold Catheter |
| Hospira, INC. | $19.84 | 2025 | |
| Viatris Specialty LLC | $16.95 | 2025 | Yupelri |
| Nabriva Therapeutics, Plc | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Munir Hazbun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.